Bausch + Lomb

After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale
Fierce Pharma
Thu, 12/12/24 - 11:47 pm
Bausch + Lomb
M&A
TPG, Blackstone bid for Bausch + Lomb in potential $14 billion deal
Economic Times
Mon, 10/14/24 - 11:23 pm
Bausch + Lomb
M&A
TPG
Blackstone
B+L Rumored to be Looking at Potential Sale to Fully Separate from Parent Company
Medical Devices and Diagnostics Industry
Mon, 09/16/24 - 10:26 pm
Bausch + Lomb
Medtech
Bausch Health
Joseph Papa, after leaving Bausch, begins another turnaround project as CEO of Emergent BioSolutions
Fierce Pharma
Wed, 02/21/24 - 11:16 am
Joseph Papa
Pharma CEOs
Emergent BioSolutions
Bausch + Lomb
Bausch + Lomb’s Faces of Glaucoma brings clarity to silent thief of sight
Medical Marketing and Media
Mon, 01/22/24 - 10:08 pm
Bausch + Lomb
glaucoma
pharma marketing
Why Shares of Bausch Health Companies Fell Tuesday
Motley Fool
Tue, 09/19/23 - 10:17 pm
Bausch + Lomb
Norwich Pharma Services
patents
Bausch + Lomb seeks funding for eye drug acquisition from Novartis
BioPharma Dive
Wed, 09/13/23 - 11:32 am
Bausch + Lomb
Novartis
M&A
Xiidra
Bausch + Lomb's Saunders doesn't expect more big deals in the near term
Reuters
Fri, 08/4/23 - 10:19 am
Bausch + Lomb
Pharma CEOs
Brent Saunders
earnings
M&A
Bausch + Lomb Buys J&J’s Dry Eye Drops for $106.5M in Expansion of OTC Business
BioSpace
Thu, 07/6/23 - 11:32 am
Bausch + Lomb
dry eye disease
OTC
JNJ Vision
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
Healio
Fri, 06/30/23 - 10:10 am
Bausch + Lomb
M&A
Novartis
Xiidra
dry eye disease
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
BioSpace
Thu, 06/15/23 - 09:58 am
Pharma CEOs
executive compensation
Sarepta Therapeutics
Pfizer
Bausch + Lomb
Amneal Pharmaceuticals
Thermo Fisher
IQVIA
McKesson
Royalty Pharma
Charles Rivers Laboratories
Seagen
Bausch + Lomb ‘reshaping’ executive team
NJ Biz
Thu, 06/1/23 - 06:29 pm
Bausch + Lomb
executives
reorganization
FDA Approves Bausch + Lomb, Novaliq Dry Eye Disease Drug
BioSpace
Fri, 05/19/23 - 10:23 am
Bausch + Lomb
Novaliq
Miebo
FDA
dry eye disease
Brent Saunders to Return as Bausch + Lomb CEO
US News Money
Wed, 02/15/23 - 10:58 am
Brent Saunders
Bausch + Lomb
Joseph Papa
Pharma CEOs
B+L Set to Acquire AcuFocus in Busy M&A Month
Medical Devices and Diagnostics Industry
Tue, 01/17/23 - 11:00 pm
Bausch + Lomb
AcuFocus
Medtech
M&A
Bausch + Lomb debuts line of eye, ear and wellness products for dogs
Medical Marketing and Media
Mon, 10/24/22 - 11:06 pm
Bausch + Lomb
animal health
Project Watson
Venture financing holds steady for device makers
EP Vantage
Fri, 07/22/22 - 10:05 am
devices
Medtech
venture capital
IPOs
Bausch + Lomb
Billiontoone
Biofourmis
Enable Injections
Meihua
Saluda Medical
Tenon Medical
Akorn Inc. Scores Two Generic Approvals from the FDA
BioSpace
Fri, 04/19/19 - 10:40 am
Akorn
FDA
generics
Flonase
GSK
Lotemax
Bausch + Lomb
Valeant Pharma's (VRX) Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
Street Insider
Mon, 07/9/18 - 06:46 pm
Valeant Pharmaceuticals
Bausch + Lomb
FDA
sub-micron loteprednol etabonate